HALOZYME THERAPEUTICS INC

CUSIP: 40637HAD1 Class: NOTE 0.250% 3/0

SHENKMAN CAPITAL MANAGEMENT INC's Holding History (CIK: 0001275228)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 3,602,000 Value ($000) $4,220 Avg Close — Range —
Q2 2025
Shares 482,000 Value ($000) $501 Avg Close — Range —
Q1 2025
Shares 3,300,000 Value ($000) $3,509 Avg Close — Range —
Q4 2024
Shares 6,814,000 Value ($000) $6,715 Avg Close — Range —
Q3 2024
Shares 23,289,000 Value ($000) $23,601 Avg Close — Range —
Q2 2024
Shares 17,141,000 Value ($000) $16,617 Avg Close — Range —
Q1 2024
Shares 8,369,000 Value ($000) $7,640 Avg Close — Range —
Q4 2023
Shares 7,960,000 Value ($000) $7,009 Avg Close — Range —
Q3 2023
Shares 9,019,000 Value ($000) $7,768 Avg Close — Range —
Q2 2023
Shares 8,615,000 Value ($000) $7,158 Avg Close — Range —
Q1 2023
Shares 8,934,000 Value ($000) $7,582 Avg Close — Range —
Q4 2022
Shares 12,403,000 Value ($000) $11,989 Avg Close — Range —
Q3 2022
Shares 8,279,000 Value ($000) $7,014 Avg Close — Range —
Q2 2022
Shares 7,889,000 Value ($000) $6,921 Avg Close — Range —